FDA Inspection 1332824 — St. Mary's Regional Medical Center
The FDA completed an inspection of St. Mary's Regional Medical Center on Jul 30, 2026 in Lewiston, ME. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 30, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lewiston, ME (United States)